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Repetitive transcranial magnetic stimulation (rTMS) is a safe and painless method for
stimulating cortical neurons. In neurological realm, rTMS has prevalently been applied to
understand pathophysiological mechanisms underlying movement disorders. However,
this tool has also the potential to be translated into a clinically applicable therapeutic
use. Several available studies supported this hypothesis, but differences in protocols,
clinical enrollment, and variability of rTMS effects across individuals complicate better
understanding of efficient clinical protocols. The aim of this present review is to discuss
to what extent the evidence provided by the therapeutic use of rTMSmay be generalized.
In particular, we attempted to define optimal cortical regions and stimulation protocols
that have been demonstrated to maximize the effectiveness seen in the actual literature
for the three most prevalent hyperkinetic movement disorders: Parkinson’s disease (PD)
with levodopa-induced dyskinesias (LIDs), essential tremor (ET) and dystonia. A total of
28 rTMS studies met our search criteria. Despite clinical and methodological differences,
overall these studies demonstrated that therapeutic applications of rTMS to “normalize”
pathologically decreased or increased levels of cortical activity have given moderate
progress in patient’s quality of life. Moreover, the present literature suggests that altered
pathophysiology in hyperkinetic movement disorders establishes motor, premotor or
cerebellar structures as candidate regions to reset cortico-subcortical pathways back
to normal. Although rTMS has the potential to become a powerful tool for ameliorating
the clinical outcome of hyperkinetic neurological patients, until now there is not a clear
consensus on optimal protocols for these motor disorders. Well-controlled multicenter
randomized clinical trials with high numbers of patients are urgently required.
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INTRODUCTION
Alteration in dynamics of neural connectivity is the hallmark of motor and behavioral disease
in humans. Brain connectivity affected by functional deficits will either produce exacerbated
or reduced brain signal and thus the observed clinical symptomatology. In the motor domain,
presence of hyperkinetic movement disorders is typically manifested as increased muscular activity
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that leads to involuntary and unwanted movements, abnormal
postures or combination of both. These are present in
several neurological disorders, such as essential tremor (ET),
dystonia, and Parkinson’s disease (PD). In contrast, hypokinetic
movement disorders represent loss of vigor and movement that
produces rigidity and the inability to initiate and terminate
actions efficiently, present in bradykinesia or freezing of gait
in PD. Current treatments are mainly pharmacological, but
recently functional surgery has made progress in remediation
of uncontrolled and unwanted motor disorders (Fasano and
Lozano, 2015).
The basal ganglia are considered the main neurodegenerative
site of hyper- and hypo-kinetic movement (Middleton and
Strick, 2000; Hamani et al., 2004). Due to its strict relationship
with several brain regions, the basal ganglia are considered
the principal hub of the neural pathways involved in motor
control, which included other regions such as the subthalamic
nucleus (STN), globus pallidum (GP), thalamus, together with
the supplementary motor area (SMA), motor cortex (M1),
and frontal regions (Alexander et al., 1986; Kehagia et al.,
2013). In the last few years, advances in the neurophysiological
and neuroimaging fields have provided alternative scenarios
for understanding the neurobiological mechanisms of motor
disorders. Indeed, several lines of evidence support the notion
that others structures, outside traditional striato-thalamo-cortical
pathways, are strongly involved. In particular, the cerebello-
thalamic circuitry (Pinto et al., 2003; Lehéricy et al., 2013) as well
as intra-cortical connections between the premotor cortex and
the inferior frontal cortex (IFC), would seem to play a key role in
the dysfunctional pathophysiological model of some hyperkinetic
motor disorders (Herz et al., 2014; Cerasa et al., 2015).
When traditional treatments fail or do not reach the expected
motor benefit, it is now possible to modulate the pathological
level of cortical activity using invasive methods such as deep
brain stimulation (Diamond and Jankovic, 2005). However,
considerable effort is being made on applying other methods
that are non-invasive, less costly, and capable of producing
beneficial effects in the long-term. The increasing number
of research and clinical protocols using non-invasive brain
stimulation protocols in patients with neurological conditions
show intermixed effects and reports. To date, therapeutic trials
using repetitive transcranial magnetic stimulation (rTMS) in
PD, ET or dystonia have reported some controversial findings.
The use of inhibitory brain stimulation to reduce excessive and
abnormal cortical activity in hyperkinetic motor disorders is a
potential tool to remediate motor control, posture, muscle tone,
and cognitive problems, but considerable effort is needed to test
the multiple available protocols when using brain stimulation
tools in neurological patients (Ridding and Rothwell, 2007; Elahi
et al., 2009).
The present review aims to focus on studies using transcranial
brain stimulation protocols to modulate hyperkinetic
neurological disorders aimed at clarifying the optimal conditions
in which non-invasive stimulation may be used in movement
disorders. We selected studies with constrained search in
PubMed and Medline using as search terms: dyskinesias,
dystonia, and ET in combination with widely used brain
stimulation terms: TMS, rTMS, and TBS, from inception to
September 25, 2015. Publication lists of relevant studies were
later scanned for potential eligible articles. We summarize key
technical aspects of rTMS with effective results for PD, ET,
and dystonia to propose focused research plans to increase the
positive impact of non-invasive brain stimulation in clinical
practice.
rTMS Protocol for Therapeutic Purpose
rTMS has effects on the brain and behavior that outlast the period
of stimulation due to plastic changes of long-term potentiation or
depression in synaptic connections amongst cortical networks.
Regions or networks with suboptimal functioning after brain
damage or neurodegenerative disease are potential candidates for
neuromodulation therapy. So far, the therapeutic use of rTMS has
been proved effective in patients withmajor depression refractory
to regular treatment (George et al., 2013). In neurological realm,
movement disorders has received much attention with regard
to rTMS therapeutic studies. However, experiments in healthy
subjects suggest that rTMS protocols have short-lived after-
effects. Hence, clinical neuroscience encounters a challenge with
aim boosting longer time-periods of beneficial effects in patient’s
quality of life.
Despite illness, several rTMS protocols may be used for
therapeutic purpose (for review see Ridding and Rothwell, 2007).
The key aspect to consider is how to prolong rTMS positive
effects in clinical conditions and quality of life. Current rTMS
protocols apply low frequency (<1Hz) or high frequency (>1Hz),
as well as single rTMS ormultiple rTMS sessions. Generally, high
frequency stimulation induces an increase in cortical excitability
and low frequency stimulation causes a decrease in cortical
excitability. To benefit plastic and long-term rTMS potentiation,
multiple sessions tend to show stronger and cumulative effects in
clinical and behavioral measures. An alternative use of rTMS is
theta burst stimulation (TBS), consisting of short, repeated bursts
of TMS pulses at 50Hz (Huang et al., 2005). Again, the use of
TBS allows decrease (using continuous TBS) or increase (using
intermittent TBS) of cortical excitability using different sets of
magnetic trains.
The fact that cortical baseline activity may be either
hyperexcitable or hypoexcitable has formed the idea of using
low-frequency rTMS to treat disorders with marked cortical
hyperexcitability, while using high frequency rTMS in conditions
with low cortical excitability. For this reason, in hyperkinetic
motor disorders the rationale behind the application of rTMS
protocol is to reduce abnormal cortical hyperexcitability,
although this is not true in all the circumstances as it depends
on several methodological and clinical factors, discussed in the
present review.
THERAPEUTIC POTENTIAL OF rTMS IN
PARKINSON’S DISEASE PATIENTS
PD is primarily a disorder of response initiation characterized
by an excessive motor inhibition. In particular, bradykinesia
(slowness of voluntary movements), tremor, rigidity, and gait
problems are cardinal motor signs in PD, greatly improved by
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treatments with dopamine replacement therapy. However, PD-
related neurochemical changes are long-lasting and difficult to
contrast by pharmacological interventions. For this reason, new
treatment strategies have been proposed. rTMS has been studied
as an intervention to ameliorate motor symptoms (Edwards et al.,
2008; Elahi et al., 2009), including rigidity and bradykinesia,
motor complications of therapy (e.g., dyskinesias) and non-
motor symptoms, mainly depression and speech (Lefaucheur
et al., 2004). Despite a large heterogeneity among these studies
(Koch, 2013), it was proposed that high frequency rTMS (i.e.,
5Hz) applied over M1 could turn as a gold-standard use in PD
to significantly reduce motor signs as measured by UPDRS-III
(Elahi et al., 2009). Moreover, the diverse results provided by the
literature indicate updating in future interventions, which will
necessitate separation of PDmotor signs in an attempt to separate
the diverse pathophysiology present in tremor, bradykinesia,
rigidity, and gait problems. In case where such separation turns
successful, perhaps we could foresee new ways of understanding
and treating PD symptoms alternatively.
rTMS in Parkinson’s Disease Patients with
Levodopa-Induced Dyskinesias
Nowadays, treating secondary motor signs related to PD
treatments is a possibility based on clear pathophysiological
models to reach effective targets. Despite pharmacological or
non-pharmacological interventions, after 4–6 years of levodopa
therapy, a significant proportion of patients exhibit a decline in
the therapeutic efficacy of levodopa and develop disabling motor
symptoms, termed levodopa-induced dyskinesias (LIDs). The
time-to-onset and severity of this motor complication show large
individual variability thus limiting the long-term use of levodopa
and clinical strategies aimed at reducing LIDs manifestation.
In the last few years, a considerable effort has been
made to understand the neurobiological basis of this motor
complication. LIDs are classically ascribed to the degree of
nigrostriatal neurodegeneration and striatal changes associated
with chronic levodopa therapy (Obeso et al., 2000). These
interact to induce maladaptive striatal plasticity, which has the
effect of altering neuronal activity in striato-pallidal circuits.
The pioneering works of Rascol et al. (1998) and Brooks et al.
(2000) demonstrated in vivo that these abnormal neuronal firing
patterns extended on the brain cortex mainly including the
sensorimotor areas of the cortico-basal ganglia loop.
After these first functional neuroimaging studies, for a
long time no additional neuroimaging investigations have
been performed on LIDs patients. From 2010 to date, new
functional and structural neuroimaging studies have shed new
light on the pathophysiological mechanisms underlying LIDs
suggesting that that LIDs-related symptoms may originate in
brain network beyond the “classical” basal ganglia dysfunctional
model, including cortical regions strongly involved in motor
inhibition processes. Indeed, what has clearly been demonstrated
was that PD patients with LIDs are characterized by dysfunctional
coupling between the prefrontal cortex, including the right IFC
and the SMA and basal ganglia measured at rest (Cerasa et al.,
2015), during a simple finger-tapping task (Cerasa et al., 2012) or
during a GoNo-Go task (Herz et al., 2014, 2015). Moreover, these
functional abnormalities in LIDs patients were also mirrored
by abnormal anatomical changes detected in the SMA and IFC
(Cerasa et al., 2011, 2013a,b). These findings have already raised
an interesting scientific debate on the toxic effects of levodopa
on brain morphometry (Vernon and Modo, 2012; Cerasa et al.,
2014) and on the hypothetical role of the prefrontal cortex as a
new target for brain stimulation useful to decrease the severity
of LIDs (Cerasa and Quattrone, 2014a,b; Obeso and Strafella,
2014a,b; Rothwell and Obeso, 2015), seen to improve motor
inhibition due to compensatory processes of interconnected
regions (Obeso et al., 2013; Zandbelt et al., 2013).
Indeed, to treat secondary effects of principal treatments in
PD such as LIDs is also an actual necessity and priority. Guided
by imaging results, rTMS over regions showing functional
overactivity in LIDs was reported either over the SMA (Koch
et al., 2005; Brusa et al., 2006) or over the IFC (Cerasa et al.,
2015) (Table 1). Otherwise, no significant or moderate effects
emerged when TMS protocol was applied over the primary
motor cortex (Wagle-Shukla et al., 2007; Filipovic et al., 2009;
Kodama et al., 2011; Filipovic´ et al., 2013; Cerasa et al., 2015). In
particular, the Koch’s group was the first in using rTMS approach
with therapeutical purpose (Koch et al., 2005). In 2005, they
demonstrated that one single session of rTMS at low frequency
(1Hz) over the SMA produced significant motor improvements
in eight patients with LIDs. The rationale behind the choice to
stimulate SMA is based either on previous neuroimaging findings
describing functional overactivity in this region (Rascol et al.,
1998; Brooks et al., 2000) or on the notion that repeated sessions
of premotor cortex stimulation induces cumulative changes in
the excitability over the primary motor cortex (Bäumer et al.,
2003). With this in mind, Brusa et al. (2006) tried to translate
this single TMS protocol in a prolonged therapeutic session (5
days), failing to demonstrate a clear beneficial effect. Contrarily,
prolonged session (2 weeks) applied on the bilateral cerebellar
cortex using high frequency (50Hz) cTBS, showed persistent
clinical beneficial effects in LIDs patients for up to 4 weeks
(Koch et al., 2009). To explain this discrepancy, these authors
proposed that this might be dependent upon the fact that the
cerebellum has greater plastic mechanisms involved in motor
learning (Ito, 2008) compared to SMA and therefore could
be susceptible to more sustained rTMS-induced changes, thus
leading to marked clinical beneficial effects. Moreover, recent
evidence suggested a causal role of the effective cerebello-cortical
connectivity in motor inhibition (Picazio and Koch, 2015), a
cognitive domain strongly involved in the pathophysiological
mechanisms of LIDs (Cerasa et al., 2015). The intimate link
between motor inhibition and LIDs has also been confirmed in
a recent study (Cerasa et al., 2015) where it was demonstrated
that a single session of continuous but not intermittent or sham
TBS applied over the right IFC was able to significantly reduce
the amount of dyskinesias as measured by the conventional
abnormal involuntary movement scale (AIMS).
The primary goal of the motor inhibition system (mainly
composed by STN, basal ganglia, SMA, and IFC) is to
control/modulate the primary motor output pathway. Idiopathic
PD is primarily a disorder of response initiation characterized
by an excessive motor inhibition (i.e., akinesia, bradykinesia),
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TABLE 1 | rTMS application on PD with LIDs.
References Sample TMS protocol Anatomical
localization
Main findings
Koch et al., 2005 8 Dyskinetic PD Single Session rTMS train at 1Hz
or 5Hz
SMA Single Session Low frequency (1Hz): reduced
AIMS after 15min
Single Session High frequency (5Hz): induced
a slight but not significant effect
Brusa et al., 2006 10 Dyskinetic PD Single and Prolonged (5 days)
sessions rTMS train at 1Hz
SMA Single Session Low frequency (1Hz): reduced
AIMS and improved UPDRS scores after 15min
Prolonged Session Low frequency (1Hz): failed
to enhance beneficial effects
Wagle-Shukla et al., 2007 6 Dyskinetic PD Prolonged (2 weeks) sessions
rTMS train at 1Hz
M1 Prolonged Session Low frequency (1Hz):
induced a slight but not significant effect
Filipovic et al., 2009 10 Dyskinetic PD Prolonged (4 days) sessions
rTMS train at 1Hz
M1 Prolonged Session Low frequency (1Hz):
induced a modest beneficial effect
Kodama et al., 2011 Case Report PD with painful
off-period dystonia
Single Session rTMS train at
0.9Hz
M1 Single Session Low frequency over M1:
reduced painful dystonia and walking
disturbances
SMA Single Session Low frequency over SMA:
induced no significant effects
Filipovic´ et al., 2013 Case Report PD with diphasic
dyskinesia
Prolonged (4 days) sessions
rTMS train at 1Hz
M1 Prolonged Session Low frequency (1Hz):
yielded beneficial effects in the upper limb
Koch et al., 2009 10 Dyskinetic PD Prolonged (2 weeks) sessions
cTBS 3 pulse bursts at 50Hz
Cerebellum Prolonged Session High frequency (50Hz):
yielded beneficial effects
Cerasa et al., 2015 11 Dyskinetic PD Single Session cTBS 3 pulse
bursts at 50Hz
Right Inferior
Frontal Cortex
Single Session High frequency (50Hz): reduced
AIMS after 45min
M1 Single Session High frequency (50Hz): failed to
enhance beneficial effects
PD, Parkinson’s disease; LIDs, Levodopa-Induced Dyskinesias; SMA, Supplementary Motor Area; M1, Primary motor cortex; rTMS, repetitive Transcranial Magnetic Stimulation; iTBS,
intermittent theta burst Transcranial Magnetic Stimulation; cTBS, continuous theta burst Transcranial Magnetic Stimulation; AIMS, Abnormal Involuntary Movement Scale.
whereas LIDs are clearly a clinical expression of disinhibition of
movement. For this reason, the recent neuroimaging evidence
strongly supports the idea that dysfunctions of the primary
motor system in LIDs patients are related to that of motor
inhibition pathway. However, it remains to be clarified why
clinical beneficial effects are evident after rTMS over the cortical
regions involved in the motor inhibition system (SMA and IFC),
whereas brain stimulation on the primarymotor cortex produced
conflicting results (Wagle-Shukla et al., 2007). Indeed, Wagle-
Shukla et al. (2007), using a prolonged session (2 weeks) of
low frequency (1HZ) rTMS over the primary motor cortex, did
not report evident clinical improvements in 6 PD patients with
LIDs. This preliminary evidence has also been confirmed in a
recent study (Cerasa et al., 2015), despite the employment of a
different TMS protocol [single session high-frequency (50Hz)
cTBS]. Three additional studies, otherwise, reported moderate
evidence about the role of the primary motor cortex as potential
stimulation site for LID treatment. First, Filipovic et al. (2009),
using low-frequency rTMS (1Hz) for 4 consecutive days in
10 PD patients with LIDs, reported residual beneficial clinical
effects in dyskinesia severity. With the same TMS protocol,
these authors found an increased beneficial effect also in one
PD patient with diphasic dyskinesia, which is far less studied
than more common peak-of-dose dyskinesias (Filipovic´ et al.,
2013). Finally, in another case report, 0.9Hz rTMS over primary
motor area significantly reduced the painful dystonia andwalking
disturbances in one dyskinetic patient with painful off-period
dystonia (Kodama et al., 2011).
To sum up, the current literature on therapeutic trials of rTMS
in PD patients with LIDs is in its relative infancy, and nowadays
there is insufficient information to support evidence-based
clinical protocols. However, the search for the most effective
protocol leads us to the conclusion that brain stimulation on
cortical regions part of the motor inhibition network (IFC, SMA,
and cerebellum) might be highly promising as therapeutical sites
for treatment of LID. Otherwise, evidence provided by rTMS
over the primary motor cortex requires further confirmation.
Indeed, while in idiopathic PD a plethora of studies demonstrated
the beneficial effects on motor symptoms after high-frequency
stimulation of the primary motor cortex (Edwards et al., 2008),
in dyskinetic patients the high clinical heterogeneity, as well as
variability in TMS protocols prevents us from making a general
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conclusion about these findings. The lack of consistency is also
dependent upon the fact that advanced neuroimaging has not yet
clarified how levodopa influences neurofunctional activity in the
motor cortex.
THE POTENTIAL USE OF rTMS TO TREAT
DYSTONIA
Dystonia is a hyperkinetic movement disorder mainly
characterized by excessive and painful muscle contraction
producing muscle twists, abnormal posture, and inefficient
moves. Body limbs involved in such muscles alteration classify
the diverse types of dystonia. Focal dystonia are those where
abnormal participation of muscles and gestures give raise to
painful postures within an isolated body region. Meanwhile,
segmental dystonia must involve two or more adjacent body
regions and generalized dystonia, which affects upper and lower
limbs of the body (Marsden, 1976). According to its etiology,
dystonia can be divided into primary dystonia, dystonia plus
syndrome or secondary dystonia (Marsden, 1976). Primary
dystonia corresponds to those patients showing no brain lesions
as revealed by structural MRI scans. It is well known that
primary dystonia can be task-specific, altering movements
involved in fine motor control (such as writer’s cramp), speaking
(dysphonia), playing piano, or running (Breakefield et al., 2008).
This dystonia form may be idiopathic or genetic, based on a
variety of more than 30 genes involved in the disease (Bragg et al.,
2011). Secondary dystonia results from stroke or traumatic brain
injury or induced by certain treatments thus has a certain origin.
However, the causes of most dystonia are unknown but some
monogenic subtype alterations (in DYT1, DYT6, or DYT13) are
considered potentially relevant in developing dystonic motor
symptoms (Bragg et al., 2011).
Considering the etiology heterogeneity in dystonia, its
pathophysiological model may vary across dystonia subtypes.
Based on clinico-pathological studies in patients with
symptomatic dystonia (Marsden et al., 1985) and intracranial
recordings from the GPi and thalamus (Vitek et al., 1999;
Zhuang et al., 2004), dystonia is considered a basal ganglia
disorder (Berardelli et al., 1998; Zheng et al., 2012). Indeed,
DBS produces a significant positive response over the GPi
(Vidailhet et al., 2005) and reduces metabolic activity over
important cortical regions part of fronto-striatal loops [i.e., the
dorsolateral prefrontal cortex (DLPFC) or the orbitofrontal
cortex (OFC); Detante et al., 2004]. Recent findings from
neuropathological data show in a large cohort of adult and child
dystonia significant reductions of substantia nigra neurons as
compared to controls (Iacono et al., 2015). This evidence has
also been confirmed by positron emission tomography (PET)
studies. Indeed, using dopaminergic markers at rest, some
groups have pinpointed cell loss over striatal and cortical regions
in primary dystonia (Otsuka et al., 1992; Berman et al., 2013).
Moreover, increased glucose metabolism over the lentiform
nucleus and cortical motor regions including SMA, lateral
premotor cortex, anterior cingulate cortex (ACC), and DLPFC
have also been reported in primary dystonia (Eidelberg et al.,
1995; Odergren et al., 1998; Ibáñez et al., 1999; Pujol et al., 2000;
Oga et al., 2002; Butterworth et al., 2003; Lerner et al., 2004).
Functional alterations in dystonic patients were also coupled
by underlying anatomical brain abnormalities. Indeed, patients
with cervical dystonia, blepharospasm, or writer’s cramp are
characterized by anatomical changes in the basal ganglia, motor
and premotor cortices, cerebellum and SMA (Eidelberg et al.,
1995; Berardelli et al., 1998; Draganski et al., 2003; Zheng et al.,
2012).
However, dystonia is not only considered to be dependent
upon the basal ganglia-thalamo-cortical pathway (Breakefield
et al., 2008), but recent evidence strongly highlights the
involvement of the cerebellar cortex and its direct connections
with the motor cortex (Lehéricy et al., 2013; Neumann et al.,
2015). Cerebellar modulation over motor cortex seems to
be compromised in dystonia patients and M1 excitability
(i.e., intra-cortical facilitation) seems responsive to cerebellar
rTMS (Brighina et al., 2009). However, it should bear in
mind that although dystonic patients are not characterized by
evident cerebellar motor signs (i.e., loss of balance or frequent
falling), it has been proposed that the cerebellum in dystonia
patients might be involved in compensatory modulation of
the abnormal activity detected in the motor cortex, or as a
potential effective input to modulate basal ganglia dysfunctional
state (Wu and Hallett, 2013). Moreover, previous evidence
points to altered cerebellar activation along the inhibitory motor
circuits in dystonia (Huang et al., 2011; Koch et al., 2014), thus
increasing the probability of such loops as potential candidate for
neuromodulation.
The role of cortico-striatal and cerebellar-thalamo-
cortical loops in dystonia, thus support two open accesses
to cortical neuromodulation over motor, premotor, or cerebellar
targets. The target location problem in dystonia seems rather
straightforward based on current pathophysiological knowledge.
So far, studies using rTMS to treat dystonia motor signs have
reported beneficial clinical effects when targeting stimulation
to motor (Odergren et al., 1998; Ibáñez et al., 1999; Pujol et al.,
2000; Oga et al., 2002; Butterworth et al., 2003; Lerner et al., 2004;
Murase et al., 2005; Allam et al., 2007; Angelakis et al., 2013;
Berman et al., 2013) or somatosensory regions (Borich et al.,
2009; Havrankova et al., 2010), but less clinical beneficial effects
after cerebellar stimulation (Koch et al., 2014; Sadnicka et al.,
2014) (see Table 2). Positive and acute effects after cerebellar
stimulation in one study (Koch et al., 2014) offer new insights
to further assess stimulation protocols with aim maintenance
of prolonged positive effects (although not every study assessed
long-term effects, Table 2). However, the gold-standard in
dystonia seems to be targeting motor regions that produce
functional changes over basal ganglia (Bharath et al., 2015).
The apparent efficient parameters to find positive results
in dystonia seem to be closely associated to the number of
stimulation sessions. Some single session studies have shown
effective results (Murase et al., 2005; Tyvaert et al., 2006; Furuya
et al., 2014) but are less persistent across time. This single session
protocols stimulating premotor regions (at low frequencies)
reported motor improvement (hand writing) in focal hand
dystonia patients (Siebner et al., 1999; Lefaucheur et al., 2004;
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TABLE 2 | rTMS application on dystonia.
References Sample TMS Protocol Anatomical
localization
Main findings
Siebner et al.,
1999
16 WC Single session rTMS at 1Hz,
placebo controlled
M1 Single session yielded positive results as measured
by pen pressure reductions and self-reported
improvement
Lefaucheur
et al., 2004
3 secondary
dystonia
Prolonged sessions (5
consecutive days) rTMS at 1Hz
Premotor Prolonged session yielded positive results in
movement rating scale and decrease in painful axial
spams
Murase et al.,
2005
9 WC Single session (1 day) rTMS at
0.2Hz
Premotor Single session yielded positive results over premotor
site, in decrease contraction and pen pressureSMA
M1
Tyvaert et al.,
2006
8 WC Single session (1 day) rTMS at
1Hz
Premotor Single session yielded positive results in handwriting
velocity and decreased discomfort
Allam et al.,
2007
1 cervical
dyst./WC
Prolonged sessions (5
consecutive days) rTMS at 1Hz
Premotor Prolonged session yielded positive results in a single
case study in cervical dystonia
Borich et al.,
2009
6 FHD Prolonged sessions (5
consecutive days) rTMS at 1Hz
Premotor Prolonged session rTMS yielded reduced cortical
excitability and improved handwriting performance
were observed and maintained at least 10 days9 HC
Havrankova
et al., 2010
20 WC Prolonged sessions (5
consecutive days) rTMS at 1Hz
Somatosensory Prolonged sessions yielded positive results in
subjective and objective writing maintained for
3-week time period
Schneider
et al., 2010
5 WC Single session (1 day) rTMS train
at 5Hz fMRI pre vs. post rTMS
Somatosensory Single session no effects in frequency discrimination
task in patients linked to decrease in GPi5 HC
Benninger
et al., 2011
12 FHD (6
sham)
Prolonged sessions (3 in 1 week)
Cathodal tDCS
M1 contralateral
to FHD
Prolonged sessions of tDCS yielded no positive
effects in clinical measures nor handwriting and
cortical excitability
Kimberley
et al., 2013
12 FHD Prolonged session (5 days) at
1Hz rTMS
Dorsal premotor Prolonged sessions yielded beneficial effects in pen
force at day 1 and 5
Furuya et al.,
2014
10 FHC
(pianists)
Single session of tDCS (cathodal
or anodal over affected or
unaffected side)
M1 Single session yielded rhythm sequence
improvement using cathodal tDCS over affected
cortex10 HC
Sadnicka
et al., 2014
10 WC Single session anodal tDCS
(sham controlled)
Cerebellum Single session tDCS revealed no positive effects in
clinical measures
Koch et al.,
2014
18 cervical
dystonia
Prolonged sessions (2 weeks)
cTBS
Bilateral
cerebellum
Prolonged sessions yielded positive acute results
(immediate effect after 2-week cTBS) in clinical
scales
Bharath et al.,
2015
19 WC
20 HC
Single session (1 day) rTMS train
at 1Hz; fMRI pre vs. post
Premotor Single session reduction in left cerebellum,
thalamus, globus pallidus, putamen, bilateral
supplementary motor area, medial prefrontal lobe
WC, writer’s cramp; HC, healthy controls; FHD, focal hand dystonia; ICD, Idiopathic cervical dystonia; CD, cerebellar dystonia; cTBS, continuous theta burst stimulation; rTMS, repetitive
transcranial magnetic stimulation; tACS, transcranial alternating current stimulation; AMT, active motor threshold; tDCS, transcranial direct current stimulation; M1, primary motor cortex;
SMA, supplementary motor area.
Murase et al., 2005). Others reported beneficial clinical effects,
as measured by subjective clinical evaluations using 1Hz rTMS
(Murase et al., 2005; Tyvaert et al., 2006), but not always single
session turns useful in dystonia (using 5Hz rTMS; Schneider
et al., 2010). Moreover, single sessions are influenced by patient’s
expectancy or state-dependent effects. Studies that opted for
multiple sessions (5 consecutive days) however provide positive
and promising results in clinical terms (Lefaucheur et al., 2004;
Borich et al., 2009; Angelakis et al., 2013; Kimberley et al.,
2013; Koch et al., 2014). Following multiple sessions rTMS,
Frontiers in Neuroscience | www.frontiersin.org 6 January 2016 | Volume 9 | Article 486
Obeso et al. rTMS Application in Movement Disorders
TABLE 3 | rTMS application on essential tremor.
References Sample TMS protocol Anatomical
localization
Main findings
Gironell et al.,
2002
10 ET Single sessions (2 days) Active vs.
sham
Cerebellum Single session acute rTMS beneficial effects on tremor,
dissipated in 1 h
rTMS train at 1Hz
Avanzino
et al., 2009
15 ET Single session Right
cerebellum
Single session rTMS yielded beneficial effects on tremor
11 HC rTMS train at 1Hz
Hellriegel
et al., 2012
10 ET Single sessions (2 days) cTBS 3
pulse bursts at 50Hz
Left M1 Single session cTBS M1 produced subclinical beneficial
effects
10 HC 80 vs. 30% AMT
Popa et al.,
2013
11 ET Prolonged sessions (5 consecutive
days)
Bilateral
cerebellum
Prolonged Session rTMS yielded beneficial effects on
tremor during 3 weeks
rTMS train at 1Hz
Chuang et al.,
2014
13 ET Single sessions (3 days) cTBS 3
pulse bursts at 50Hz
M1, premotor
and sham
Single session cTBS modulated cortical excitability for
shorter duration in ET patients18 HC
ET, essential tremor; HC, healthy controls; cTBS, continuous theta burst stimulation; rTMS, repetitive transcranial magnetic stimulation; AMT, active motor threshold; M1, primary motor
cortex.
plastic changes in dystonic patients lasted 10 days post-treatment
(Borich et al., 2009) and importantly, subjective perception of
well-being was maintained for a 3-week period (Havrankova
et al., 2010). Others reported only acute amelioration of dystonic
signs after cTBS, however after cerebellar stimulation (Koch
et al., 2014) thus suggesting premotor regions as responsive for
multiple neuromodulation sessions in dystonia.
Regarding rTMS stimulation protocols, the disparity in
frequency of stimulation (i.e., low vs. high frequencies) is a
solid factor of variability in the current literature. Most of
the available literature reports low frequencies (see Table 3),
although higher ones, i.e., cTBS, do produce enhanced clinical
effects. In Koch et al. (2014), 2-week of TBS applied bilaterally
over the cerebellumwas compared against a shamTBS condition.
Patients under the active stimulation showed ameliorated clinical
conditions acutely, but not persistently, with a marked decrease
in muscle contraction evaluated by a blinded neurologist. In
a similar protocol, following 1Hz rTMS applied over the left
somatosensory parietal region inWC patients (Havrankova et al.,
2010), patients showed subjective and objective improvements
in writing quality during a 3-week time period. Similarly, using
1Hz rTMS over dorsal premotor area produced positive results
in pen force use and general patients mobility (Kimberley et al.,
2013). Such increment in patients response to rTMS may be
driven by the fact that low frequency rTMS seems to modulate
somatosensory integration in patients with dystonia and WC
(Bäumer et al., 2007). Thus, the working hypothesis is that use
of repeated sessions may induce cortical plasticity that induces
facilitation of sensory outputs or facilitation of contralateral
hemisphere (Bharath et al., 2015) to control motor functions.
Further evidence is urgently needed to confirm the use of
multiple rTMS sessions and to determine ways of prolonging its
duration.
Stimulation over cortical premotor and motor regions
connecting with basal ganglia renders a potential treatment in
dystonia characterized by functional and compensatory changes
in the subcortical regions. Still, greater accuracy in the protocols
used to induce subcortical changes are needed. TMS studies
trying to induce enhancement of dystonic signs have mostly
tackled regions part of the basal ganglia motor loops, i.e., motor,
premotor, SMA, and somatosensory regions. The necessity to test
alternative TMS protocols under different dystonic symptoms or
use stimulation techniques in combination with medication or
rehabilitation is obvious.
TURNING DOWN HYPERACTIVE
CEREBELLO-THALAMIC LOOPS IN
ESSENTIAL TREMOR WITH rTMS
ET is a hyperkinetic motor disorder that affects one or more body
parts by inducing involuntary and rhythmic movements. This
may occur in a single limb or at any body part, such as a chin or
head with larger prevalence in upper limbs (Helmich et al., 2013).
Typically, is presented while moving, bilaterally or kinetic tremor
that is visible and persistent. Today, the use of pharmacological
in treatment of ET remains poor and unsatisfactory (Louis,
2015). In contrast, surgical treatment is effective in reducing
hand tremor in 95% of patients and improved function in 74%,
however with added potential risks being an invasive approach
(Sandvik et al., 2012).
ET has been associated with altered oscillatory activity in
the motor loop involving the cerebello-thalamo-cortical network
(Pinto et al., 2003). Several imaging and animal evidence are
in keeping with this view of the disease. Indeed, dysfunctional
activities (measured as fMRI or PET) and anatomical changes
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FIGURE 1 | Optimal brain targets of stimulation for therapeutic
purposes. rTMS targeting the premotor regions and supplementary motor
area (SMA, colored in blue) has been demonstrated as the most plausible site
of stimulation for reducing hyperkinetic motor disorders in PD patients with
levodopa-induced dyskinesias. Moreover, either the premotor or the primary
motor cortices (colored in red) are the most frequently used cortical targets for
dystonic patients. Finally, based on the literature, the cerebellum (colored in
green) has been proposed as the best target for maximizing the effectiveness
of rTMS in patients with essential tremor. Of interest, the premotor region is an
effective region for two hyperkinetic disorders: dyskinesias and dystonia
(colored in red/blue). Figure summarizes (Koch et al., 2005; Brusa et al., 2006;
Tyvaert et al., 2006; Popa et al., 2013).
(gray and white matter atrophies) have been found in the well-
known tremor network (Hallett, 2014), as well as in a plethora of
other brain regions involving M1, GPi, thalamus, or cerebellum
(Passamonti et al., 2011). However, both functional and structural
imaging studies reported convergent findings about the role of
the cerebellum as the most consistent area of pathology in ET.
This hypothesis has also been confirmed by recent post-mortem
studies (Louis et al., 2007, 2011) where it was demonstrated that
the average amount of cerebellar Purkinje cells is reduced 25% in
tremor patients compared to controls.
Either motor or cerebellum regions are the main target
regions to use in neuromodulation for ET. This is mainly guided
following results from cortical infarction over motor regions, in
which ET motor signs disappeared (Le Pira et al., 2004; Kim
et al., 2006). Similarly, single magnetic pulses over M1 seemed to
modulate postural tremor in PD patients (Pascual-Leone et al.,
1994). These results are in part explained by the correlated
frequencies in hand tremor and cortical activity (Hellwig et al.,
2001). Yet, rTMS studies trying to apply long-lasting modulatory
stimulation in ET have focused over cerebellum andM1 (Gironell
et al., 2002, 2014; Avanzino et al., 2009; Hellriegel et al., 2012;
Popa et al., 2013; Chuang et al., 2014).
Overall, four studies reported positive anti-tremoric effects
using prolonged sessions of rTMS, for a time-period of 3 weeks
in ET patients refractory to medical treatment (see Table 3).
Beneficial clinical effects assessed by a tremor rating scale (Fahn-
Tolosa-Marin tremor scale) were shown as acute and lasting
reductions in tremor amplitude and substantial improvement
in functional disability (drawing, writing) after rTMS (Popa
et al., 2013). Moreover, baseline functional connectivity showed
impaired activity in the cerebello-thalamic-cortical loop, a
dysfunction that was reset back to near normal levels after rTMS
(Popa et al., 2013). The lack of a sham group leaves their results
as pending to rule out possible placebo effects.
Historically, the first rTMS application on ET patients was
performed by Gironell et al. (2002), who reported acute positive
effects after a single session of 1Hz rTMS over the cerebellum.
The study was double blind, crossover, and placebo-controlled
design. Their results were significant just in acute evaluation on
subjective assessments performed by patients. The nature of their
study was exploratory with limited sample size and makes results
hard to interpret due to its moderate and transient effects. Next,
a second study (Avanzino et al., 2009) using a single session
of unilateral 1Hz cerebellar TMS stimulation, also reported
a transient improvement in motor scores evaluated using a
tapping task. However, no translational results into clinical scores
were found. By contrast, inhibitory cTBS of the left primary
motor hand area for 2 consecutive days yielded significant
motor benefits by reducing tremor total power, assessed with an
accelerometer (Hellriegel et al., 2012). Similarly, Chuang et al.
(2014) were interested to alter motor cortical dysfunction in ET
by applying cTBS over the primary motor and premotor cortices.
They found that cTBS was capable of producing a suppressive
effect on motor cortical excitability in ET patients, but the
effects lasted for a significantly shorter time compared with
the effect produced in healthy individuals. Clinically speaking,
tremor amplitude was decreased significantly after cTBS but the
tremor frequency remained unchanged. The authors concluded
that inhibitory circuits within the motor cortex are aberrant and
less modifiable in ET patients.
Mechanistically, cerebellar rTMS seems to turn back-to-
normal the altered activity in tremor by re-establishing an
appropriate synaptic plasticity involved in programming of
motor plans (Ito, 2008), resulting in the most plausible
candidate target for ET. It turns, thus, possible to boost tremor
sign reduction using rTMS protocols with bilateral cerebellar
stimulation and low frequency types under multiple rTMS
sessions.
CONCLUSIONS
The results of this systematic review show that there was not
a clear consensus on optimal protocols to be used for these
motor disorders. Future studies are key to consolidate the use
of rTMS in this clinical context in order to reduce hyperkinetic
brain dysfunctions. However, some positive results give clinical
researchers hints of effective neuromodulatory paradigms and
uses. Beneficial effects will most likely be boosted if: (i) prolonged
sessions are possible, (ii) the use of low frequency rTMS
(i.e., 1Hz), (iii) samples selection restricted to those patients
refractory to regular medical treatment, and (iv) choosing the
adequate target based on known cortical regions altered in
pathophysiological models. Figure 1 represents a summary of
candidate regions for treating hyperkinetic dysfunction based on
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the present literature. Optimal cortical regions that have been
demonstrated to maximize the effectiveness of rTMS protocols
are: (i) the premotor cortex and SMA for dyskinesias in PD; (ii)
the motor and premotor cortices for dystonic patients; and (iii)
the cerebellum for patients with ET.
Still, basic procedures or techniques, such as cTBS in tremor
or combined therapies (different motor rehabilitation programs
and rTMS) have not yet been applied in these disorders. Also, if
rTMS protocols are used with patient samples grouped by disease
onset and symptom type we may expand knowledge on patient-
dependent states and how TMS may modulate differently at each
disease stage or symptomatology.
The reader should also note that in this review we neglected
some other important hyperkinetic movement disorders such
as, Huntington’s disease and Tourette syndrome. With respect
to Huntington’s disease where the application of rTMS for
therapeutic purpose is in its relative infancy (Berardelli and
Suppa, 2013; Philpott et al., 2013), the large amount of works
in psychiatric realm supported the notion that non-invasive
brain stimulation is widely recognized as a alternative non-
pharmacological approach for decreasing the frequency and
intensity of tics in patients with Tourette syndrome (Bloch et al.,
2014).
To sum up, the current literature on therapeutic trials of rTMS
in hyperkinetic movement disorders patients is still ambiguous,
and there is need of well-controlled multicenter randomized
clinical trials to define the most effective protocol. However,
advancements in technology, as well as, in pathophysiological
understanding will improve the effectiveness of this safe
and potentially therapeutic option in hyperkinetic movement
disorder patients.
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